The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46.
Molson Coors Beverage Company
TAP · a US exchange · USD · Market cap $7.4B · 16,200 employees
Molson Coors Beverage Company manufactures, markets, distributes, and sells beer and other malt beverage products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 10:20 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price40.84 USD at the 13 Nov 2026 close
- Our value readFair vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.34)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $35.53 to $57.73, base estimate $40.98 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-09-25
- Options put/call open interest 0.34, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Molson Coors Beverage Company holds its Markup at $40.84. Consolidating, no directional conviction, held for 9 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 9 days |
| Price at the screen | $40.84 |
| Valuation | 8.63 trailing · 8.94 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.45 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Brewers | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Molson Coors Beverage does not clear the screen at the business-activity stage. It operates in alcohol, so the financial ratios are not the deciding factor here.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TAP's ethical verdict changes
Today TAP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades at roughly a 0% discount to our $40.98 fair value, weak competitive moat.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 0.3% discount to the base estimate.
Third-party analyst targets: 21 covering, consensus Hold. The average target sits +3% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere our models see it going: fair-value estimate $40.98, with a range of $35.53 to $57.73, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBeer Maker Fails on Both Books and Ethics
Walk into any local and the taps often carry Molson Coors brands, yet the company is losing money on almost every pint sold. We pass because the business activity screen blocks alcohol producers outright, and the figures give no reason to argue the point. Revenue inches up just 2 percent while margins sit at minus 19 percent and return on equity is minus 18 percent.
The forward multiple looks cheap at 8.2 times, but that only reflects peak-cycle earnings that are already sliding. A weak moat leaves it exposed to craft rivals and shifting tastes, and twenty-one analysts see little upside beyond a modest hold rating near current prices.
Currency swings, shifting regulations on alcohol, and thin cash generation add real downside that the low multiple does not offset. Analysis, not advice.
| Forward P/E | 8.9xvery cheap relative to earnings |
| Trailing P/E | 8.6xvery cheap relative to earnings |
| EPS, trailing | 4.60 |
| EPS, forward | 4.44 |
| Revenue growth | -1.6%revenue is shrinking |
| Profit margin | 8.1%thin but positive margins |
| Return on equity | 8.0%a modest return on shareholder capital |
| FCF yield | 12.20% |
| Dividend yield | 4.51% |
| Debt to equity | 0.59moderate, manageable leverage |
| Current ratio | 0.86below 1: short-term bills exceed liquid assets |
| Beta | 0.45barely tracks the market's swings |
| Short interest, float | 0.20% |
| 52-week range | 35.52 - 54.82 |
| Moat | WEAK |
| Market cap | $7.4B |
| Employees | 16,200 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTAP trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (21 analysts) rates it hold, with a mean price target of $46.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 5 Stocks Analysts Just Downgraded Yahoo Finance · 6d ago
- DraftKings downgraded, AMD upgraded: Wall Street's top analyst calls Yahoo Finance · 7d ago
- Buy, Sell, or Hold? Monday’s Top Upgrades and Downgrades: Advanced Micro Devices, Airbnb, DraftKings, L3 Harris Technologies, Molson-Coors, Nvidia, Take-Two Interactive, Uber Technologies, and More Yahoo Finance · 7d ago
- Sell Alert: 5 High-Profile Stocks Just Dumped by Top Analysts Yahoo Finance · 8d ago
- Molson Coors Beverage Q3 Earnings Call Highlights Yahoo Finance · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | HERINGTON CHARLES M | Director | 3,976 | · | |
| 2026-05-06 | MOLSON GEOFFREY E | Director | 3,976 | · | |
| 2026-05-06 | RILEY HUGH SANFORD | Director | 3,976 | · | |
| 2026-05-06 | WILLIAMS LEROY JAMES JR. | Director | 3,976 | · | |
| 2026-05-06 | EATON ROGER G | Director | 3,976 | · | |
| 2026-05-06 | WINNEFELD JAMES A. JR. | Director | 3,976 | · | |
| 2026-05-06 | TIMM JILL | Director | 3,976 | · | |
| 2026-05-06 | COCKS CHRISTIAN P | Director | 3,976 | · | |
| 2026-05-06 | O'SULLIVAN NESSA I | Director | 3,976 | · | |
| 2026-05-06 | FERGUSON-MCHUGH MARY LYNN | Director | 3,976 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $40.95 | -0.2% | $0.48 | $1,010 | +1.0% |
| 2 months | $44.52 | -8.2% | $0.48 | $929 | -7.1% |
| 3 months | $43.17 | -5.3% | $0.48 | $958 | -4.2% |
| 6 months | $46.03 | -11.2% | $0.96 | $909 | -9.1% |
| 1 year | $50.06 | -18.3% | $1.90 | $855 | -14.5% |
| 2 years | $48.19 | -15.2% | $3.72 | $925 | -7.5% |
| 3 years | $59.96 | -31.8% | $5.42 | $772 | -22.8% |
| 5 years | $51.04 | -19.9% | $8.44 | $966 | -3.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TAP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.